Danaher Co. (DHR) Shares Bought by Virtu Financial LLC

Virtu Financial LLC raised its position in shares of Danaher Co. (NYSE:DHR) by 85.7% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 20,176 shares of the conglomerate’s stock after purchasing an additional 9,309 shares during the quarter. Virtu Financial LLC’s holdings in Danaher were worth $1,873,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of DHR. Roundview Capital LLC boosted its stake in shares of Danaher by 2.0% in the second quarter. Roundview Capital LLC now owns 25,674 shares of the conglomerate’s stock worth $2,167,000 after buying an additional 502 shares during the last quarter. Honeywell International Inc. boosted its stake in shares of Danaher by 113.4% in the third quarter. Honeywell International Inc. now owns 640,100 shares of the conglomerate’s stock worth $54,908,000 after buying an additional 340,100 shares during the last quarter. Veritable L.P. raised its holdings in Danaher by 28.2% in the 2nd quarter. Veritable L.P. now owns 40,486 shares of the conglomerate’s stock worth $3,417,000 after purchasing an additional 8,912 shares during the period. Wealthfront Inc. raised its holdings in Danaher by 10.2% in the 2nd quarter. Wealthfront Inc. now owns 14,574 shares of the conglomerate’s stock worth $1,230,000 after purchasing an additional 1,348 shares during the period. Finally, Cibc World Markets Corp raised its holdings in Danaher by 28.7% in the 2nd quarter. Cibc World Markets Corp now owns 300,808 shares of the conglomerate’s stock worth $25,385,000 after purchasing an additional 67,075 shares during the period. Institutional investors and hedge funds own 77.05% of the company’s stock.

DHR has been the subject of a number of research analyst reports. Credit Suisse Group reissued a “hold” rating and set a $99.00 target price on shares of Danaher in a report on Tuesday, December 19th. Zacks Investment Research cut Danaher from a “buy” rating to a “hold” rating in a report on Tuesday, December 19th. Robert W. Baird reissued a “buy” rating on shares of Danaher in a report on Friday, January 12th. Royal Bank of Canada reissued a “hold” rating and set a $96.00 target price on shares of Danaher in a report on Thursday, January 4th. Finally, Evercore ISI initiated coverage on Danaher in a report on Wednesday, January 3rd. They set an “outperform” rating for the company. One investment analyst has rated the stock with a sell rating, five have issued a hold rating, fifteen have issued a buy rating and one has issued a strong buy rating to the company. The company has a consensus rating of “Buy” and an average price target of $100.68.

Danaher Co. (NYSE:DHR) opened at $97.54 on Tuesday. The firm has a market capitalization of $67,946.36, a P/E ratio of 27.63, a P/E/G ratio of 2.05 and a beta of 1.04. Danaher Co. has a 52-week low of $78.97 and a 52-week high of $104.82. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.43 and a quick ratio of 1.05.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Tuesday, January 30th. The conglomerate reported $1.19 earnings per share for the quarter, topping the consensus estimate of $1.16 by $0.03. The company had revenue of $5.09 billion during the quarter, compared to analyst estimates of $4.97 billion. Danaher had a return on equity of 11.36% and a net margin of 13.60%. The firm’s revenue for the quarter was up 10.9% compared to the same quarter last year. During the same period in the prior year, the business posted $1.05 earnings per share. analysts anticipate that Danaher Co. will post 4.37 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Friday, January 26th. Stockholders of record on Friday, December 29th were given a dividend of $0.14 per share. The ex-dividend date was Thursday, December 28th. This represents a $0.56 annualized dividend and a dividend yield of 0.57%. Danaher’s dividend payout ratio is currently 15.86%.

In other news, SVP Angela S. Lalor sold 42,988 shares of the firm’s stock in a transaction on Friday, February 2nd. The stock was sold at an average price of $102.29, for a total transaction of $4,397,242.52. Following the completion of the transaction, the senior vice president now directly owns 82,008 shares in the company, valued at $8,388,598.32. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, EVP William K. Daniel sold 131,066 shares of the firm’s stock in a transaction on Friday, February 2nd. The stock was sold at an average price of $102.05, for a total value of $13,375,285.30. Following the transaction, the executive vice president now owns 270,523 shares of the company’s stock, valued at $27,606,872.15. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 237,043 shares of company stock valued at $24,194,886. Company insiders own 12.20% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Danaher Co. (DHR) Shares Bought by Virtu Financial LLC” was originally published by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this story on another website, it was illegally copied and republished in violation of United States and international copyright laws. The correct version of this story can be viewed at https://stocknewstimes.com/2018/02/20/danaher-co-dhr-shares-bought-by-virtu-financial-llc.html.

About Danaher

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply